AE Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.07M | Buy |
65,053
+6,710
| +12% | +$940K | 0.05% | 305 |
|
|
2025
Q4 | $7.16M | Buy |
58,343
+14,470
| +33% | +$1.76M | 0.04% | 344 |
|
|
2025
Q3 | $4.87M | Buy |
43,873
+8,554
| +24% | +$972K | 0.03% | 369 |
|
|
2025
Q2 | $3.92M | Buy |
35,319
+7,645
| +28% | +$814K | 0.03% | 398 |
|
|
2025
Q1 | $3.1M | Sell |
27,674
-27,168
| -50% | -$2.8M | 0.03% | 437 |
|
|
2024
Q4 | $5.07M | Buy |
54,842
+5,875
| +12% | +$529K | 0.04% | 341 |
|
|
2024
Q3 | $4.11M | Buy |
48,967
+19,171
| +64% | +$1.46M | 0.04% | 369 |
|
|
2024
Q2 | $2.04M | Buy |
29,796
+3,124
| +12% | +$208K | 0.02% | 515 |
|
|
2024
Q1 | $1.95M | Sell |
26,672
-99,594
| -79% | -$7.66M | 0.02% | 494 |
|
|
2023
Q4 | $10M | Buy |
126,266
+64,467
| +104% | +$5.02M | 0.05% | 391 |
|
|
2023
Q3 | $4.63M | Buy |
61,799
+5,954
| +11% | +$458K | 0.03% | 566 |
|
|
2023
Q2 | $4.3M | Sell |
55,845
-301,991
| -84% | -$24.1M | 0.03% | 588 |
|
|
2023
Q1 | $29.7M | Buy |
357,836
+37,561
| +12% | +$3.11M | 0.19% | 121 |
|
|
2022
Q4 | $27.5M | Buy |
320,275
+43,064
| +16% | +$3.41M | 0.2% | 110 |
|
|
2022
Q3 | $17.1M | Buy |
277,211
+213,114
| +332% | +$13.4M | 0.14% | 161 |
|
|
2022
Q2 | $3.96M | Buy |
64,097
+6,383
| +11% | +$395K | 0.03% | 455 |
|
|
2022
Q1 | $3.43M | Buy |
57,714
+4,562
| +9% | +$292K | 0.02% | 549 |
|
|
2021
Q4 | $3.86M | Sell |
53,152
-7,633
| -13% | -$526K | 0.03% | 492 |
|
|
2021
Q3 | $4.25M | Buy |
60,785
+5,400
| +10% | +$379K | 0.04% | 421 |
|
|
2021
Q2 | $3.81M | Buy |
55,385
+13,605
| +33% | +$908K | 0.03% | 446 |
|
|
2021
Q1 | $2.7M | Sell |
41,780
-4,902
| -11% | -$316K | 0.03% | 489 |
|
|
2020
Q4 | $2.72M | Buy |
46,682
+3,047
| +7% | +$184K | 0.03% | 408 |
|
|
2020
Q3 | $2.76M | Buy |
43,635
+8,339
| +24% | +$578K | 0.04% | 345 |
|
|
2020
Q2 | $2.72M | Sell |
35,296
-11,572
| -25% | -$887K | 0.04% | 333 |
|
|
2020
Q1 | $3.5M | Buy |
46,868
+4,351
| +10% | +$301K | 0.08% | 219 |
|
|
2019
Q4 | $2.76M | Buy |
42,517
+1,561
| +4% | +$102K | 0.06% | 277 |
|
|
2019
Q3 | $2.6M | Buy |
40,956
+14,529
| +55% | +$950K | 0.08% | 222 |
|
|
2019
Q2 | $1.78M | Buy |
26,427
+19,916
| +306% | +$1.31M | 0.05% | 265 |
|
|
2019
Q1 | $423K | Buy |
6,511
+2,163
| +50% | +$144K | 0.03% | 376 |
|
|
2018
Q4 | $272K | Sell |
4,348
-1,044
| -19% | -$73K | 0.05% | 366 |
|
|
2018
Q3 | $416K | Buy |
5,392
+1,017
| +23% | +$76.8K | 0.02% | 367 |
|
|
2018
Q2 | $310K | Sell |
4,375
-11,794
| -73% | -$833K | 0.02% | 324 |
|
|
2018
Q1 | $1.22M | Sell |
16,169
-220
| -1% | -$17.5K | 0.09% | 136 |
|
|
2017
Q4 | $1.17M | Buy |
16,389
+13,195
| +413% | +$1M | 0.1% | 133 |
|
|
2017
Q3 | $259K | Buy |
+3,194
| New | +$244K | 0.02% | 331 |
|
Other funds holding GILD
VCM
VPM
AE Wealth Management's GILD Position: Q1 2026 in Review
AE Wealth Management increased its Gilead Sciences (GILD) stake by 12% in Q1 2026, buying an estimated $940K and bringing the position to 65,053 shares worth $9.07M. The position accounts for 0.05% of the portfolio, ranked #305.
AE Wealth Management first reported a position in GILD in Q3 2017 and has held it in 35 quarters since. The position peaked at $29.7M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- AE Wealth Management held 65,053 shares of Gilead Sciences worth $9.07M as of Q1 2026.
- AE Wealth Management bought 6,710 Gilead Sciences shares in Q1 2026, an estimated $940K.
- Gilead Sciences made up 0.05% of AE Wealth Management's portfolio in Q1 2026, its #305 holding.
- AE Wealth Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 35 quarters since.
- AE Wealth Management's Gilead Sciences position peaked at $29.7M in Q1 2023.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.